NAD的前体尼古丁胺 рибоoside在体外保护对排卵后的衰老
Tianjie Li1,2,3, Yibo Wang2,3,4,5, Yang Yu2,3,4
1Department of Obstetrics and Gynecology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, 100050, China.
Journal of assisted reproduction and genetics
|October 26, 2024
概括
尼古丁胺基核糖胺 (NR) 补充剂有效地防止卵细胞的排卵后衰老 (POA),改善质量,并可能增加人工生殖技术 (ART) 的成功率. 这种天然化合物对抗氧化应激和DNA损伤,为ART提供了一个有前途的抗衰老解决方案.
科学领域:
- 生殖生物学 生殖生物学
- 分子生物学分子生物学
- 老年学是一门学科.
背景情况:
- 排卵后衰老 (POA) 显著损害了卵子质量,并减少了人工生殖技术 (ART) 的成功率.
- 在POA中的分子变化包括活性氧物种 (ROS) 的增加,能量耗尽和DNA损伤.
- 迫切需要采取干预措施来减轻POA的影响.
研究的目的:
- 为了研究尼古丁胺胺 рибоoside (NR) 在预防POA在体外培养过程中的潜力.
- 确定NR补充能否改善卵细胞质量并提高ART成功率.
主要方法:
- 在POA的体外模型被用来培养小鼠MII卵细胞24小时.
- 评估了形态完整性,NAD+水平,ROS积累,线粒体功能和DNA损伤 (γH2AX).
- 胚胎发育潜力,螺旋组装,染色体对齐和皮质颗粒分布在NR补充时被评估.
- 通过qRT-PCR测量了抗氧化酶Sod1和Gpx1的mRNA表达.
主要成果:
- 补充NR (200μM) 降低了ROS,改善了线粒体功能,并纠正了POA卵细胞中的皮质颗粒错位.
- 通过NAD+/SIRT1通路,NR治疗抑制了氧化应激,恢复了轴/染色体对齐,并降低了γH2AX水平.
- 这些改善表明胚胎发育潜力增强.
结论:
- 尼古丁胺胺核糖胺 (NR) 是一种安全有效的天然化合物,用于预防卵细胞排卵后衰老.
- NR显示出作为一种抗衰老疗法的潜力,可以改善ART的临床结果.
相关概念视频
Mitochondria
11.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
11.3K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K


